A Study of IBI311 in Subjects With Active Thyroid Eye Disease

NCT05795621 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Eye Disease

Interventions

BIOLOGICAL: IBI311
BIOLOGICAL: placebo

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.